Triglycerides and residual risk

202063 citationsReview

Authors

Antonio J. Vallejo‐Vaz · Imperial College London

Pablo Corral · Universidad Fraternidad de Agrupaciones Santo Tomás de Aquino

Laura Schreier · University of Buenos Aires

Abstract

Evidence suggests higher triglycerides are a marker of CVRisk and may help identify patients who benefit from intensification of therapy. Moreover, genetic studies support a causal link between TRL/triglycerides and cardiovascular disease. Treatment with high-dose EPA may be of benefit in high-risk patients with hypertriglyceridemia to reduce CVRisk.

Topics & Keywords

Lipoproteins and Cardiovascular Health Diabetes, Cardiovascular Risks, and Lipoproteins Cancer, Lipids, and Metabolism

Publication Details

Published in: Current Opinion in Endocrinology Diabetes and Obesity

Volume 27, Issue 2, pp. 95-103

DOI: 10.1097/med.0000000000000530

Field-Weighted Citation Impact: 9.51

Command Palette

Triglycerides and residual risk

Authors

Abstract

Topics & Keywords

Publication Details